Concepedia

Publication | Open Access

A randomized evaluation of the TriGuard™ HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: the REFLECT I trial

DOIFull Paper Access

65

Citations

30

References

2021

Year

Alexandra J. Lansky, Rajendra Makkar, Tamim Nazif, Steven R. Messé, John K. Forrest, Rahul Sharma, Joachim Schöfer, Axel Linke, David L. Brown, Abhijeet Dhoble,
European Heart Journal

Abstract

REFLECT I demonstrated that TG cerebral protection during TAVR was safe in comparison with historical TAVR data but did not meet the predefined effectiveness endpoint compared with unprotected TAVR controls.

References

YearCitations

Page 1